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Objective:  The  objective  of  this  study  was  to assess  the  interleukin  10 (IL-10)  concentrations
in  the  sera  of  dogs  suffering  from  demodicosis.
Methods:  Twenty-six  dogs  were  distributed  into  three  groups:  demodicosis  groups  G1,
n = 11  (recurring  disease)  and  G2, n  =  6 (ﬁrst  time  occurrence),  and  a control  group,  G3,
n = 9 (healthy  dogs).  All  the  animals  were  subjected  to skin  scrape  tests  and  blood  harvest-
ing  for  serum  extraction.  In  G1  and  G2  only  those  animals  with  Demodex  canis  positive  skin
tests were  included,  while  healthy  dogs  were  included  in  G3.  To  assess  IL-10  levels  the
commercial  Quantikine  Canine  IL-10  Immunoassay® (R&D  Systems)  kit  was  used.nterleukin 10 Results:  The  mean  IL-10  level  obtained  for G1  was  269.4  pg/ml  (sd  = 290.8  pg/ml),  for  G2
it was  28.5  pg/ml  (sd  =  19.7  pg/ml)  while  the mean  for G3  was  11.9 pg/ml  (sd  =  2.3  pg/ml).
There  was  a signiﬁcant  difference  between  G1  and  the  other  two  groups.
Conclusions:  According  to our  results,  dogs  with  reoccurring  demodicosis  have  higher  IL-10
levels than  healthy  dogs  and  those  suffering  the  disease  for the  ﬁrst  time.. Introduction
Demodicosis is a canine dermatopathy caused by the
xcessive proliferation of the Demodex canis mite due to
nherited, cell-mediated, immune deﬁciency (Delayte et al.,
006). Generalized demodicosis is considered one of the
ost severe canine skin diseases, and is frequently asso-
iated with secondary bacterial infections (Paradis, 1999;
ueller, 2004).
Immunosuppression is directly associated with the
evelopment of the disease, whether caused by other inﬁr-
ities or not (Gortel, 2006). Common inﬁrmities associated
ith demodicosis are malignant tumors, hepatopathies,
nd hyperadrenocorticism. There is no evidence of humoral
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immune response involved in the process (Tizard, 2002),
with reports of severe T cell reduction in dogs with
chronic demodicosis (Caswell et al., 1997). Cytokines
have an important role in the regulation of the immune
response, and their expression pattern seems to contribute
to the clinical presentation of the disease (Tani et al.,
2002).
Previous works have described cytokine patterns in
dogs suffering from demodicosis. Lemarié and Horohov
(1996) reported a decrease of both Il-2 production and
expression of their receptors in mononuclear cells. Tani
et al. (2002) assessed the expression of several cytokines
(IFN-, IL-2, IL-4, IL-5, IL-10, TNF-, TGF-, and GAPDH) in
mononuclear blood cells, they suggest that IL-5 may  be a
key factor in monitoring the disease. The CD4+ cells/CD8+
Open access under the Elsevier OA license.cells ratio is considered to be implicated in the pathogen-
esis of the disease, and lower ratios are associated with
worse responses to treatment (Singh et al., 2010; Tsuneo
et al., 2005).
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IL-10 was ﬁrst discovered based on its capacity to
inhibit cytokine secretion by mouse T-helper 1 (Th1)
cells, and this cytokine is an essential molecule in
the mechanism underlying suppression mediated by
T regulatory cells (Moore et al., 1990). Interleukin-10
has anti-inﬂammatory and suppressive effects on most
hematopoietic cells, and it indirectly suppresses cytokine
production and proliferation of antigen-speciﬁc CD4+ T
effector cells, by inhibiting the antigen-presenting capac-
ity of different types of professional antigen-presenting
cells (Roncarolo et al., 2006). Their targets are Th1 cells,
B cells, macrophages, NK cells, mast cells, and thymocytes
(Tizard, 2002). IL-10 is also called the cytokine synthe-
sis inhibitor factor, since it has the ability to inhibit the
synthesis of Th1 cytokines (IL-1, IFN-, and TNF-) as
well as inhibiting the function of NK cells (Howard and
O’garra, 1992). The purpose of this work was to deter-
mine the levels of systemic IL-10 in dogs suffering from
demodicosis.
2. Material and methods
This study was carried out with 26 dogs, 12 males and
14 females. The dogs were divided into three groups, those
positive for demodicosis (G1 n = 11, and G2 n = 6) and a
control group of healthy dogs (G3 n = 9). Animals in the
demodicosis groups were all dogs admitted to the vet-
erinary hospital of the Universidade Federal de Pelotas
(HCV-UFPel) requiring treatment for skin diseases, the
animals in the control group were healthy dogs of the
veterinary school’s animal facility. The inclusion criteria
for animals in G1 and G2 was a positive skin scrape test,
with live, adult and immature forms of the mite. Further-
more the animals had to present with at least two large
areas in the body, consistent with generalized demodico-
sis, as well as erythema, pyoderma (pustules with purulent
exudation), and lymphadenopathy. Animals in G1 were
dogs with reoccurring demodicosis (at least one previous
case of the disease). Their age ranged from four month
to eight years. All 11 animals were mixed breeds and
had been unresponsive to previous therapy with either
moxidectin or ivermectin. Animals in G2 were mani-
festing the disease for the ﬁrst time, these were mixed
breed dogs aged from one to six years. To be included
in G3, the skin scrape test had to be negative for of
Demodex canis, with the absence of skin disease for at
least the previous six months and no medications dur-
ing this period. The only fact speciﬁcally veriﬁed prior to
this was the absence of demodicosis. The skin scrape test
was performed in three different areas of the animals’
bodies, and observed under a light microscope at 100×
magniﬁcation.
The animals were subjected to blood collection by
venopuncture of the cephalic or jugular vein. The blood
was stored in vaccutainer tubes with no anticoagulant,
centrifuged at ∼2000 × g for 5 min  in order to obtain
the serum. The sera, collected from May  to December
2009, were kept in 1.5 mL  microtubes at −20 ◦C until
use. The sera were assessed for IL-10 levels through
a sandwich ELISA using the Quantikine Canine IL-10
Immunoassay® (R&D Systems) kit, according to thetology 193 (2013) 312– 315 313
manufacturers speciﬁcations. All sera were tested in
triplicates.
The statistical analyses was  conducted with the
mean results of the triplicates in the ELISAS. For
the comparison between groups the ANOVA was
used, and a Welch test was  used to compare the
averages.
3. Results
Clinical evaluation and skin scrape tests were carried
out successfully and allowed the adequate distribution of
the study groups. Collected serum samples were stored to
be processed together.
The IL-10 ELISA revealed an average 269.4 pg/mL
(sd = 290.8 pg/mL) in animals from G1, 28.5 pg/mL
(sd = 19 pg/mL) in animals from G2, and 11.9 pg/mL
(sd = 19.7 pg/mL) in animals from the control group G3.
Individual IL-10 levels can be viewed in Table 1. IL-10
levels in G1 were signiﬁcantly higher than in the other
groups (G2: p = 0.02 and G3: p = 0.01), while no signiﬁcant
statistical difference was observed between groups G2 and
G3.
4. Discussion
The results obtained in this study indicate that high IL-
10 levels during the severe clinical period of demodicosis
may  be an important factor for the reoccurrence of the
disease. Interleukin 10 is a multifunctional cytokine pro-
duced by T cells, and as such it regulates the activity of
a variety of cells in the immune system, and may  have a
crucial role in the regulation of different types of T cells
(Mosmann, 1996). Consequently, IL-10 activity may  com-
promise Th1 response, as was suggested by Lemarié and
Horohov (1996).  Our results suggest that the Th1 deﬁciency
and the low IL-2 levels (Lemarié and Horohov, 1996) may
occur as a result of the inhibitory action of IL-10, present in
high quantities in the serum of dogs suffering from gener-
alized reoccurring demodicosis.
Tani et al. (2002) assessed the IL proﬁle of dogs suffering
from chronic demodicosis and revealed a normal expres-
sion of IL-2 mRNA. Those authors suggest that the reduced
Th1 response would be linked to a decreased IFN produc-
tion, and unrelated to IL-2 concentrations (Tani et al., 2002).
However, that study did not ﬁnd an altered expression
of IL-10. We  demonstrate that IL-10 levels are consid-
erably altered in dogs suffering recurring demodicosis,
as IL-10 has an inhibitor effect on IFN-gamma produc-
tion (Fiorentino et al., 1989), it may  be the cause of the
decreased IFN-gamma in dogs with demodicosis. These
discrepant results are likely due to the fact that Tani and co-
workers assessed the expression of mRNA and in this study
the concentrations of IL-10 in the serum were measured
directly.
When groups G2 and G3 were compared, no signiﬁcant
difference was observed, although IL-10 concentrations in
G2 were higher than those in G3. On the other hand, G1
was signiﬁcantly different from both G2 and G3. These
results suggest that dogs admitted for the ﬁrst time may
be suffering from a onetime immunological disorder, while
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Table 1
Interleukin 10 levels of the studied dogs.
Group Animal IL-10 level (pg/ml) Meana (pg/ml) SD (pg/ml)
G1 reoccurring demodicosis A 5.25 269.39A 290.75
B  40.25
C 298
D 557.75
E 39.5
F 69
G 114
H 56.25
I 729
J 269.75
K 784.5
G2  First time demodicosis L 39 28.54B 19.71
M  4.5
N 24
O 51.75
P 7.5
Q 44.5
G3  Healthy control R 13.56 11.94B 2.27
S  9.24
T 11.82
U 10.2
V 15.54
W 13.86
X 12
12.66
8.58
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Z 
a Different letters indicate statistically different values (p < 0.05).
hose with recurring clinical signs are suffering from a more
evere and chronic immunodeﬁciency. These results are
n line with those described by Singh et al. (2010) who
ound different responses in dogs suffering from general-
zed or localized demodicosis, when assessing CD4+/CD8+
ell ratio.
The association between immunological disorders and
he development of demodicosis has poorly known mech-
nisms (Tani et al., 2002; Singh et al., 2010). There is
till need for thorough research to uncover in what way,
peciﬁcally, the organism interacts with the mite. The
ltered immune response allows the excessive prolifer-
tion of the mite, thus generating the clinical disease
Barriga et al., 1992). The aggravation of the dog’s clin-
cal state occurs with the installation of opportunistic
icroorganisms (Herni et al., 2006), generating the pyo-
erma that usually accompany demodicosis. In this light,
levated IL-10 levels may  be considered a relevant fac-
or to explain why some animals develop demodicosis.
tudies to reveal the underlying conditions that cause
he elevated IL-10 levels must be undertaken, as well
s the development and use of drugs that modulate the
mmune response in order to minimize these predisposing
actors.
This study reveals that IL-10 concentrations may
nﬂuence the clinical outcome of dogs suffering from
emodicosis. Furthermore, we have shown that, while
ogs with ﬁrst time demodicosis seem to have com-
arable IL-10 levels to those of healthy dogs, animals
ith reoccurring symptoms have signiﬁcantly higher lev-
ls than both the aforementioned groups, and this may  be
he underlying predisposition for the reoccurrence of the
isease.Acknowledgments
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